PTEN and prostate carcinoma: As the same miR can target multiple mRNAs, studies have reported miR-22 direct targeting of PTEN in prostate cancer (Poliseno et al., 2010) and downregulation of PTEN protein levels in RWPE1 prostate cancer cells ectopically expressing miR-22 (Dhar et al., 2017).